Menotrophin Intermediate: Customizable FSH/LH Ratios for Specialty Formulations

While standard menotrophin (HMG) contains a 1:1 ratio of FSH to LH, some pharmaceutical developers require customized ratios for specific patient populations or clinical protocols. Customization is achieved by selectively enriching or depleting the LH fraction during the chromatography process.

This capability is particularly valuable for companies developing niche fertility products, such as those for patients with hypogonadotropic hypogonadism (where LH supplementation is critical) or for ovulation induction protocols that favor higher FSH activity.